Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1902

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 8
Chunk 1902
---
ents 
    $127,603  
    $185,595 
  
    Website Development Costs 
     104,622  
     79,248 
  
    Intangible Assets, at cost 
     232,225  
     264,843 
  
    Accumulated Amortization 
     (75,141) 
     (37,585)
  
    Intangible Assets, net 
    $157,084  
    $227,258 

During the years ended December 31, 2024 and
2023, the Company capitalized website development-related costs of $25,374 and $52,178, respectively, in connection with the upgrade
and enhancement of functionality of the corporate website at www.60degreespharma.com. Amortization expense for the years ended December
31, 2024, and 2023 was in the amount of $38,502 and $29,157, respectively.

The following table summarizes the estimated
future amortization expense for our patents and website development costs as of December 31, 2024:

    Period 
    Patents  
    Website Development Costs 
  
    2025 
    $6,810  
    $31,761 
  
    2026 
     6,810  
     12,432 
  
    2027 
     6,810  
     3,094 
  
    2028 
     6,810  
     - 
  
    2029 
     6,810  
     - 
  
    Thereafter 
     35,953  
     - 
  
    Total 
    $70,003  
    $47,287 

The Company additionally has $40,172 in capitalized
patent expenses that will become amortizable as the patents they are associated with are awarded.

F-19

6. STOCKHOLDERS’ EQUITY

Pursuant to the Certificate of Incorporation
of 60 Degrees Pharmaceuticals, Inc., the Company’s authorized shares consist of (a) 150,000,000 shares of common stock, par value
$0.0001 per share and (b) 1,000,000 shares of preferred stock, par value $0.0001 per share, of which 80,965 have been designated as Series
A Non-Voting Convertible Preferred Stock (“Series A Preferred Stock”). As of December